Pharmaceutical & Drug Policy
Amicus brief in support of HHS cross-motion for summary judgment
Pharmaceutical & Drug Policy
Workshop summary: Technology solutions for improving the resilience of generic prescription drug manufacturing
Manufacturing & Supply Chains
Marta Wosińska’s testimony before the Senate Finance Committee
Pharmaceutical & Drug Policy
Incorporating information on therapeutic alternatives into the IRA prescription drug negotiations